Tera Science Extends Davolink Stake Sale of 4.9 Billion KRW for Financial Restructuring, Limited Share Price Impact
Tera Science amended the sale date of 2.5 million shares in Davolink, its largest affiliate, for 4.875 billion KRW to July 23, 2026.
The stated purpose is improvement of financial structure, with funds likely used for operational needs or debt repayment.
This disposal does not involve any change in Tera Science's outstanding shares, so there is no dilution risk for existing shareholders.
However, repeated amendments to the same disclosure suggest uncertainty regarding the counterparty or execution timeline.
The disposal amount represents about 7% of Tera Science's market cap of approximately 695.7 billion KRW, limiting the impact on financial structure.
No treasury stock acquisition or dividend announcements were made.
[AI Summary]This amendment signals a neutral impact on Tera Science's stock price due to repeated delays and lack of dilution. While the cash inflow could support financial health, the persistent uncertainty surrounding the transaction may offset any positive effect.
KOSDAQ Filing Information
[Correction of Description] Disposal Decision of Stocks and Investment Securities of Other Corporations (Voluntary Disclosure)